Cindy Jacobs
Principal investigator, leads ACHIEVE LIFE SCIENCES, INC..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$2.8MFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $2.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 25, 2023 | NIH | SBIR Phase II Benefit and Safety of Cytisinicline (cytisine) for Cessation of Nicotine E-cigarette Use | $585K | ACHIEVE LIFE SCIENCES, INC. |
| May 27, 2022 | NIH | SBIR Phase II Benefit and Safety of Cytisinicline (cytisine) for Cessation of Nicotine E-cigarette Use | $1.9M | ACHIEVE LIFE SCIENCES, INC. |
| Jul 20, 2021 | NIH | STTR Phase II Benefit and Safety of Cytisinicline (cytisine) for Cessation of Nicotine E-cigarette Use | $320K | ACHIEVE LIFE SCIENCES, INC. |
Peer ranks
Federal funding#673
Awards as PI#822
Patents#273
Companies
- ACHIEVE LIFE SCIENCES, INC.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.